Evidence map›Paper›PMID 31534134›Full record

ArticleNature communications2019

Modular enzyme assembly for enhanced cascade biocatalysis and metabolic flux.

Wei Kang, Tian Ma, Min Liu, Jiale Qu, Zhenjun Liu, Huawei Zhang, Bin Shi, Shuai Fu, Juncai Ma, Louis Tung Faat Lai and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 272 citations in OpenAlex.

  1. Pooled it
  2. Synthetic and systems biotechnology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Strategies for Metabolic Engineering ofMolecules (Basel, Switzerland) · 2026
    Review
  10. Review
  11. Metabolic Engineering ofChem & bio engineering · 2026
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Efficient production of astaxanthin inSynthetic and systems biotechnology · 2025
    Article
  17. Article
  18. Metabolic engineering ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Wei KangDepartment of Chemistry, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Tian MaKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education and School of Pharmaceutical Sciences, Wuhan University, 430071, Wuhan, China.ORCID http://orcid.org/0000-0001-6555-4192
Min LiuDepartment of Chemistry, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Jiale QuDepartment of Chemistry, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Zhenjun LiuDepartment of Chemistry, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Huawei ZhangSchool of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Bin ShiKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education and School of Pharmaceutical Sciences, Wuhan University, 430071, Wuhan, China.
Shuai FuJ1 Biotech Co., Ltd., 430075, Wuhan, China.
Juncai MaSchool of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Louis Tung Faat LaiSchool of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Sicong HeDepartment of Electronic and Computer Engineering, Center of Systems Biology and Human Health, School of Science and Institute for Advanced Study, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, China.
Jianan QuDepartment of Electronic and Computer Engineering, Center of Systems Biology and Human Health, School of Science and Institute for Advanced Study, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, China.ORCID http://orcid.org/0000-0002-6809-0087
Shannon Wing-Ngor AuSchool of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Byung Ho KangSchool of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.ORCID http://orcid.org/0000-0002-4299-2170
Wilson Chun Yu LauSchool of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.ORCID http://orcid.org/0000-0002-3069-8513
Zixin DengKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education and School of Pharmaceutical Sciences, Wuhan University, 430071, Wuhan, China.
Jiang XiaDepartment of Chemistry, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China. jiangxia@cuhk.edu.hk.ORCID http://orcid.org/0000-0001-8112-7625
Tiangang LiuKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education and School of Pharmaceutical Sciences, Wuhan University, 430071, Wuhan, China. liutg@whu.edu.cn.ORCID http://orcid.org/0000-0001-8087-0345
Chinese University of Hong Kong · HKWuhan University · CNHong Kong University of Science and Technology · HKShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzymatic reactions in living cells are highly dynamic but simultaneously tightly regulated. Enzyme engineers seek to construct multienzyme complexes to prevent intermediate diffusion, to improve product yield, and to control the flux of metabolites. Here we choose a pair of short peptide tags (RIAD and RIDD) to create scaffold-free enzyme assemblies to achieve these goals. In vitro, assembling enzymes in the menaquinone biosynthetic pathway through RIAD-RIDD interaction yields protein nanoparticles with varying stoichiometries, sizes, geometries, and catalytic efficiency. In Escherichia coli, assembling the last enzyme of the upstream mevalonate pathway with the first enzyme of the downstream carotenoid pathway leads to the formation of a pathway node, which increases carotenoid production by 5.7 folds. The same strategy results in a 58% increase in lycopene production in engineered Saccharomyces cerevisiae. This work presents a simple strategy to impose metabolic control in biosynthetic microbe factories.

Indexed as

BiocatalysisBioreactorsBiosynthetic PathwaysCarotenoidsEscherichia coliLycopeneMetabolic EngineeringMevalonic AcidProtein EngineeringSaccharomyces cerevisiaeVitamin K 2CarotenoidsLycopeneMevalonic AcidVitamin K 2

Identifiers

PMID31534134
PMCPMC6751169
OpenAlexW2973533038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.